OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
South Florida storm dumps more than a foot of rain
African Governments Step Up Demands for Share of Carbon Profits
Phenom and Pontoon Partner to Deliver Supercharged Talent Experiences to Global Organizations with AI and Automation
G-20 Aims to Triple Renewables and Gives Caveat to Fossil Fuels
Jack Ma’s Lieutenants Return to Oversee Tough Alibaba Reboot
Accenture Invests in Stardog to Help Companies Optimize their Data Insights and Value
TikTok responds to reports of users sharing letter from bin Laden
Mysterious yellow glass found in Libyan desert 'caused by meteorite', say scientists